Penwest is a specialty pharmaceutical company that develops drugs based on their innovative oral drug delivery technologies. Our proprietary technologies are designed to improve patient health by optimizing the delivery and performance of medicines. Penwest's advanced oral drug delivery technologies serve as strategic tools to extend product life cycles and boost a drug's position in the pharmaceutical marketplace.

TIMERx^®, our proprietary oral controlled-release technology, is the foundation of our drug delivery technology platform. It is adaptable to soluble and insoluble drugs, flexible to a variety of release profiles, and provides easy scale-up and technology transfer to more rapidly formulate and advance products into clinical trials.

From the TIMERx platform, we have developed two additional and distinct oral drug delivery systems: Geminex^® and SyncroDose^TM. Geminex is a dual drug delivery system which provides independent release of combined drug actives and SyncroDose is a drug delivery system which releases the drug at the desired site and time in the body.